These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen. Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781 [TBL] [Abstract][Full Text] [Related]
24. Tamoxifen and the endometrium. Seidman JD; Kurman RJ Int J Gynecol Pathol; 1999 Oct; 18(4):293-6. PubMed ID: 10542935 [No Abstract] [Full Text] [Related]
25. [Vinylestrenolone: a new progestational hormone. Results of its cyclic administration]. Boris Rubio L Minerva Ginecol; 1966 Nov; 18(21):1215-7. PubMed ID: 5997085 [No Abstract] [Full Text] [Related]
28. Endometrial changes in patients receiving tamoxifen therapy. Neven P N Y State J Med; 1991 Apr; 91(4):168. PubMed ID: 2047038 [No Abstract] [Full Text] [Related]
29. [Clinical evaluation of the antioestrogenic agent tamoxifen in the treatment of metastatic breast cancer (author's transl)]. Szepesi T; Czech W Wien Klin Wochenschr; 1978 Feb; 90(4):133-41. PubMed ID: 625990 [TBL] [Abstract][Full Text] [Related]
30. [Bromocriptine in the treatment of normal prolactinemic anovulation]. Messalli E; Quirino R; Ricciardi I; Torella M Riv Ital Ginecol; 1980; 59(2-3):111-8. PubMed ID: 7256097 [No Abstract] [Full Text] [Related]
31. [Evaluation of the estrogenicity of various synthetic estrogens by means of vaginal hormonocytology]. Teter J; Krzywdzinski K Rev Fr Endocrinol Clin; 1971; 12(1):9-20. PubMed ID: 4944905 [No Abstract] [Full Text] [Related]
32. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens. Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396 [TBL] [Abstract][Full Text] [Related]
33. Management of anovulation. Adams M; Cooke ID Clin Obstet Gynaecol; 1974 Aug; 1(2):285-311. PubMed ID: 4620625 [No Abstract] [Full Text] [Related]
34. [Evaluation of the effect of estriol succinate on menopausal women]. Alisedo Aparicio LE; Espinosa de los Reyes VM; Meza y Gutiérrez E Ginecol Obstet Mex; 1977 Nov; 42(253):327-36. PubMed ID: 401063 [No Abstract] [Full Text] [Related]
35. [Tamoxifen therapy in locally advanced primary and recurrent breast cancer (author's transl)]. Wada T; Koyama H; Takahashi Y; Nishizawa Y; Iwanaga T; Aoki Y; Terasawa T Nihon Gan Chiryo Gakkai Shi; 1979 Aug; 14(5):819-24. PubMed ID: 501187 [No Abstract] [Full Text] [Related]
36. [Yellow body function in bromocryptine induced early pregnancy in patients with hyperprolactinemia (author's transl)]. Smiljanić N; Ciglar S; Podobnik M Jugosl Ginekol Opstet; 1981; 21(3-4):65-9. PubMed ID: 6803072 [TBL] [Abstract][Full Text] [Related]
37. The management of anovulatory infertility. Limb DG Practitioner; 1978 Dec; 221(1326):917-20. PubMed ID: 748905 [No Abstract] [Full Text] [Related]
38. Therapeutic effect of bromocriptine in anovulatory women with normal prolactin levels. Waroński W; Blecharz A; Sobolewska M Acta Univ Palacki Olomuc Fac Med; 1981; 101():125-31. PubMed ID: 6211039 [No Abstract] [Full Text] [Related]
39. [Chemo-endocrine therapy for advanced breast cancer--a combined treatment with tamoxifen and FT 207-- (author's transl)]. Wada T; Koyama H; Nishizawa Y; Takahashi Y; Fukuda I; Iwanaga T; Terasawa T Nihon Gan Chiryo Gakkai Shi; 1981 Feb; 16(1):51-5. PubMed ID: 6790640 [No Abstract] [Full Text] [Related]
40. [Anovulatory cycles with an apparently normal level of blood prolactin. Treatment by bromocriptine]. Peillon F; Vincens M; Cesselin F; Doumith R; Mowszowicz I Nouv Presse Med; 1979 Oct; 8(40):3269-70. PubMed ID: 534188 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]